India to Netherlands: Cabazitaxel Export Trade Route
India has recorded 21 verified shipments of Cabazitaxel exported to Netherlands, representing a combined trade value of $1.2M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $56.7K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED , which accounts for 46% of total export value with 6 shipments worth $550.8K USD. On the buying side, brocacef NL HUB is the largest importer in Netherlands with $206.1K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Netherlands Cabazitaxel corridor is one of India's established pharmaceutical export routes, with 21 shipments documented worth a combined $1.2M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED , which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's cabazitaxel manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $56.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with cabazitaxel's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 15.3%, placing it at rank #6 among India's top cabazitaxel export destinations globally.
On the import side, key buyers of Indian cabazitaxel in Netherlands include brocacef NL HUB, ALLOGA France, BROCACEF NL:DUTCH and 10 others. brocacef NL HUB is the single largest importer with 3 shipments valued at $206.1K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ2
- Primary modeSea freight
- Top portMUNDRA SEA (INMUN1)
Market Position
- Global rank#6
- Annual growth+15.3%
- Demand growth+13.3%
- Regulatory ease81/100
Top 10 Indian Cabazitaxel Exporters to Netherlands
Showing top 10 of 3 Indian suppliers exporting Cabazitaxel to Netherlands, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $91.8K per shipment | 6 | $550.8K | 46.2% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $39.3K per shipment | 14 | $550.8K | 46.2% |
| 3 | INTAS PHARMACEUTICALS LTD Avg $89.4K per shipment | 1 | $89.4K | 7.5% |
This table shows the top 10 of 3 Indian companies exporting cabazitaxel to Netherlands, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 6 shipments worth $550.8K USD, giving it a 46% market share.
Top 10 Cabazitaxel Importers in Netherlands
Showing top 10 of 13 known buyers in Netherlands receiving Cabazitaxel shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian cabazitaxel in Netherlands include brocacef NL HUB, ALLOGA France, BROCACEF NL:DUTCH , BROCACEF NL:HUB , ALLOGA France , among 13 total buyers. The largest importer is brocacef NL HUB, accounting for $206.1K USD across 3 shipments — representing 17% of all cabazitaxel imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | brocacef NL HUB | 3 | $206.1K | 17.3% |
| 2 | ALLOGA France | 2 | $189.9K | 15.9% |
| 3 | BROCACEF NL:DUTCH | 1 | $163.3K | 13.7% |
| 4 | BROCACEF NL:HUB | 2 | $140.5K | 11.8% |
| 5 | ALLOGA France | 1 | $116.0K | 9.7% |
| 6 | BROCACEF NL HUB BROCACEF HEALTHCAR | 1 | $89.4K | 7.5% |
| 7 | BROCACEF NL:HUB | 1 | $87.9K | 7.4% |
| 8 | BROCACEF NL HUB | 1 | $69.6K | 5.8% |
| 9 | Brocacef NL : HUB | 1 | $61.4K | 5.2% |
| 10 | ALLOGA FRANCE | 2 | $28.5K | 2.4% |
Showing top 10 of 13 Cabazitaxel importers in Netherlands on this route.
Top 10 Cabazitaxel Formulations Imported by Netherlands
Showing top 10 of 11 product formulations shipped on the India to Netherlands Cabazitaxel route, ranked by trade value
Netherlands imports a wide range of cabazitaxel formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUG&MED:CABAZITAXEL 20MG/ML 3ML( — accounts for $391.7K USD across 4 shipments. There are 11 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUG&MED:CABAZITAXEL 20MG/ML 3ML( | 4 | $391.7K | 32.9% |
| 2 | PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML | 4 | $367.3K | 30.8% |
| 3 | PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML | 3 | $206.1K | 17.3% |
| 4 | PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML 3MLACCORD-FISE AS PER DOCUMENT | 1 | $89.4K | 7.5% |
| 5 | PHR DRUGS&MEDI CABAZITAXEL 20MG/ML 3ML(A | 1 | $69.6K | 5.8% |
| 6 | PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML 3ML(ACCORD-FRANCE AS PER INVOICE | 2 | $28.5K | 2.4% |
| 7 | PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML3ML(ACCORD-DKNOIS AS PER INVOICE | 1 | $14.3K | 1.2% |
| 8 | PHARMACEUTICAL DRUGS AND MEDICINE - CABAZITAXEL 20MG/ML 3ML(ACCORD-BELGIUM - ASPER INVOICE | 2 | $8.3K | 0.7% |
| 9 | PHARMACEUTICAL DRUGS AND MEDICINE., CABAZITAXEL 20MG/ML 3ML(ACCORD-PORTUGAL EACH ML CONTAINS CABAZITAXEL.20.0 | 1 | $6.6K | 0.6% |
| 10 | PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML3ML(ACCORD-PORTUGAL AS PER INVOICE | 1 | $5.5K | 0.5% |
Showing top 10 of 11 Cabazitaxel formulations imported by Netherlands on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA (INMUN1) handles the highest volume with 12 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's cabazitaxel exports to Netherlands are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD — together account for 100% of total trade value on this route. The average shipment value of $56.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma drugs & medi cabazitaxel 20mg/ml and pharma drugs & medi cabazitaxel 20mg/ml, suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, brocacef NL HUB is the largest importer with 3 shipments worth $206.1K USD — representing 17% of all cabazitaxel imports from India on this route. A total of 13 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.2M
- Avg. Shipment
- $56.7K
- Suppliers
- 3
- Buyers
- 13
- Transit (Sea)
- ~16 days
- Annual Growth
- +15.3%
Related Analysis
Other Cabazitaxel Routes
Unlock the Full India to Netherlands Cabazitaxel Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 21 shipments on this route.
Frequently Asked Questions — India to Netherlands Cabazitaxel Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Cabazitaxel to Netherlands?
The leading Indian exporters of Cabazitaxel to Netherlands are INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 46% of total trade value on this route.
Q What is the total value of Cabazitaxel exports from India to Netherlands?
India exports Cabazitaxel to Netherlands worth approximately $1.2M USD across 21 recorded shipments. The average value per shipment is $56.7K USD.
Q Which ports does India use to ship Cabazitaxel to Netherlands?
The most active port of origin is MUNDRA SEA (INMUN1) with 12 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Netherlands for Cabazitaxel?
The average transit time for Cabazitaxel shipments from India to Netherlands is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Netherlands Cabazitaxel trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.3% with demand growth tracking at 13.3%. The route is ranked #6 among India's top Cabazitaxel export destinations globally.
Q How many suppliers are active on the India to Netherlands Cabazitaxel route?
There are currently 3 active Indian suppliers exporting Cabazitaxel to Netherlands. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 46% of total shipment value.
Q Who are the main importers of Cabazitaxel from India in Netherlands?
The leading importers of Indian Cabazitaxel in Netherlands include brocacef NL HUB, ALLOGA France, BROCACEF NL:DUTCH , BROCACEF NL:HUB , ALLOGA France . brocacef NL HUB is the largest buyer with 3 shipments worth $206.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Netherlands export trade corridor identified from Indian Customs (DGFT) records for Cabazitaxel.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 13 importers in Netherlands matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 21 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
21 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists